1. Home
  2. RETO vs CDIO Comparison

RETO vs CDIO Comparison

Compare RETO & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RETO

ReTo Eco-Solutions Inc.

HOLD

Current Price

$2.67

Market Cap

6.1M

ML Signal

HOLD

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

N/A

Current Price

$3.51

Market Cap

5.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RETO
CDIO
Founded
1999
2017
Country
China
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
5.3M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
RETO
CDIO
Price
$2.67
$3.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
436.5K
31.0K
Earning Date
05-05-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,109,956.00
$15,782.00
Revenue This Year
N/A
$1,434.82
Revenue Next Year
N/A
$4,661.91
P/E Ratio
N/A
N/A
Revenue Growth
16864.81
N/A
52 Week Low
$1.77
$2.42
52 Week High
$61.50
$53.10

Technical Indicators

Market Signals
Indicator
RETO
CDIO
Relative Strength Index (RSI) 50.04 52.40
Support Level $1.77 $2.85
Resistance Level $3.54 $3.91
Average True Range (ATR) 0.55 0.39
MACD -0.09 0.12
Stochastic Oscillator 32.87 56.82

Price Performance

Historical Comparison
RETO
CDIO

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Machinery and Equipment sales, and Technology Consulting and other services. The company earns its revenue from the Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Share on Social Networks: